BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 15474697)

  • 1. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.
    Briguori C; Colombo A; Airoldi F; Violante A; Focaccio A; Balestrieri P; Paolo Elia P; Golia B; Lepore S; Riviezzo G; Scarpato P; Librera M; Bonizzoni E; Ricciardelli B
    Eur Heart J; 2004 Oct; 25(20):1822-8. PubMed ID: 15474697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.
    Briguori C; Visconti G; Focaccio A; Golia B; Chieffo A; Castelli A; Mussardo M; Montorfano M; Ricciardelli B; Colombo A
    J Am Coll Cardiol; 2009 Dec; 54(23):2157-63. PubMed ID: 19664895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury.
    Mulukutla SR; Marroquin OC; Smith C; Varghese R; Anderson WD; Lee JS; Cohen HA; Counihan PJ; Lee AB; Gulati V; McNamara D
    Am J Cardiol; 2004 Dec; 94(11):1363-6. PubMed ID: 15566904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.
    Yun KH; Jeong MH; Oh SK; Rhee SJ; Park EM; Lee EM; Yoo NJ; Kim NH; Ahn YK; Jeong JW
    Int J Cardiol; 2009 Nov; 137(3):246-51. PubMed ID: 18706705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.
    Chang SM; Yazbek N; Lakkis NM
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):193-7. PubMed ID: 15170709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Shiba M; Wada M; Tsuji T; Komatsu H; Iijima R; Nakajima R; Yamamoto M; Yamamoto M; Yoshitama T; Takagi T; Hara H; Sugi K
    J Cardiol; 2007 Mar; 49(3):115-23. PubMed ID: 17444137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Troponin T, Troponin I and CK-MB (mass) in the detection of periprocedural myocardial damage after coronary angioplasty].
    La Vecchia L; Bedogni F; Finocchi G; Mezzena G; Martini M; Sartori M; Castellani A; Soffiati G; Vincenzi M
    Cardiologia; 1997 Apr; 42(4):405-13. PubMed ID: 9244645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
    Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
    J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
    Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
    Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early initiation of statin therapy in patients with acute myocardial infarction after successful percutaneous coronary intervention].
    Katayama N; Nakao K; Horiuchi K; Ogawa H; Honda T
    J Cardiol; 2004 Oct; 44(4):131-40. PubMed ID: 15532243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis.
    Zhang F; Dong L; Ge J
    Ann Med; 2010 Apr; 42(3):171-7. PubMed ID: 20384433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome.
    Jia XW; Fu XH; Zhang J; Gu XS; Fan WZ; Wu WL; Hao GZ; Li SQ; Jiang YF
    Chin Med J (Engl); 2009 Mar; 122(6):659-64. PubMed ID: 19323930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.